| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2017: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2016: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2015: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
|---|
| Outline of Final Research Achievements |
This study demonstrate the development of the mucin glycan profiling targeting to surgical tissue sections from pancreatic ductal adenocarcinoma and cholangiocarcinoma. We establish the glycan profiling of mucin molecules derived from culture cells. Using this method, we next demonstrate the differential mucin glycan profiling targeting to surgical tissue sections from pancreatic ductal adenocarcinoma and cholangiocarcinoma. As the result, we find a specific glycan change according to tumor prognosis after the surgery. Our methodology is expected to applicate to newly biomarker and drug discovery in the future.
|
